Position statement on EUS-guided ablation of pancreatic cystic neoplasms from an international expert panel

Anthony Yuen-Bun Teoh; Dong Wan Seo; William Brugge; John Dewitt; Pradermchai Kongkam; Enqiang Linghu; Matthew T. Moyer; Ji Kon Ryu; Khek Yu Ho

doi:10.1055/a-0959-5870

Endoscopy International Open, Table of Contents

CC BY-NC-ND 4.0 · Endosc Int Open 2019; 07(09): E1064-E1077
DOI: 10.1055/a-0959-5870

Review

Position statement on EUS-guided ablation of pancreatic cystic neoplasms from an international expert panel

Anthony Yuen-Bun Teoh

¹Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong

,

Dong Wan Seo

²Department of Gastroenterology, Asan Medical Centre, Seoul, Korea

,

William Brugge

³Pancreas Biliary Center, Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts, United States

,

John Dewitt

⁴Division of Gastroenterology, Department of Medicine, Indiana University Hospital, Indianapolis, Indiana, United States

,

Pradermchai Kongkam

⁵Pancreas Research Unit and Gastrointestinal Endoscopy Excellent Center, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand

,

Enqiang Linghu

⁶Department of Gastroenterology, Chinese PLA General Hospital, Beijing, China

,

Matthew T. Moyer

⁷Division of GI-Hepatology and Penn State University Cancer Institute, Penn State Hershey Medical Center, Hershey, Pennsylvania, United States

,

Ji Kon Ryu

⁸Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea

,

Khek Yu Ho

⁹Department of Medicine, National University of Singapore, Singapore

› Author Affiliations

Abstract

Background and aim Recently, several guidelines with divergent recommendations on management of pancreatic cystic neoplasm have been published but the role of endoscopic ultrasound (EUS)-guided pancreatic cyst ablation has not been thoroughly addressed. The aim of the current paper is to explore the issues surrounding EUS-guided pancreatic cyst ablation by generating a list of clinical questions and providing answers based on best scientific evidence available.

Methods An expert panel in EUS-guided pancreatic cyst ablation was recruited from members of the Asian EUS group and an international expert panel. A list of clinical questions was created and each question allocated to one member to generate a statement in response. The statements were then discussed in three Internet conference meetings between October 2016 and October 2017. The statements were changed until consensus was obtained. Afterwards, the complete set of statements was sent to all the panelist to vote on strength of the statements, classification of the statement sand grading of the evidence.

Results Twenty-three statements on EUS-guided drainage of pancreatic cyst ablation were formulated. The statements addressed indications for the procedures, technical aspects, pre-procedure and post-procedure management, management of complications, and competency and training in the procedures.

Conclusion The current set of statements on EUS-guided pancreatic cyst ablation are the first to be published by any endoscopic society. Clinicians interested in developing the technique should reference these statements and future studies should address the key issues raised in the document.

Full Text

References

References
1 Tanaka M, Fernandez-del Castillo C, Adsay V. et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012; 12: 183-197
2 European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut 2018; 67: 789-804
3 Scheiman JM, Hwang JH, Moayyedi P. American Gastroenterological Association technical review on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology 2015; 148: 824-848 e822
4 Guyatt GH, Oxman AD, Vist GE. et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-926
5 Guyatt GH, Oxman AD, Schunemann HJ. et al. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol 2011; 64: 380-382
6 Oh HC, Brugge WR. EUS-guided pancreatic cyst ablation: a critical review (with video). Gastrointest Endosc 2013; 77: 526-533
7 Moyer MT, Sharzehi S, Mathew A. et al. The safety and efficacy of an alcohol-free pancreatic cyst ablation protocol. Gastroenterology 2017; 153: 1295-1303
8 Oh HC, Seo DW, Song TJ. et al. Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection treats patients with pancreatic cysts. Gastroenterology 2011; 140: 172-179
9 Dewitt J, McGreevy K, Schmidt CM. et al. EUS-guided ethanol versus saline solution lavage for pancreatic cysts: a randomized, double-blind study. Gastrointest Endosc 2009; 70: 710-723
10 Dewitt JM, Al-Haddad M, Sherman S. et al. Alterations in cyst fluid genetics following endoscopic ultrasound-guided pancreatic cyst ablation with ethanol and paclitaxel. Endoscopy 2014; 46: 457-464
11 Moyer MT, Dye CE, Sharzehi S. et al. Is alcohol required for effective pancreatic cyst ablation? The prospective randomized CHARM trial pilot study. Endosc Int Ppen 2016; 4: E603-E607
12 Choi JH, Seo DW, Song TJ. et al. Long-term outcomes after endoscopic ultrasound-guided ablation of pancreatic cysts. Endoscopy 2017; 49: 866-873
13 Gan SI, Thompson CC, Lauwers GY. et al. Ethanol lavage of pancreatic cystic lesions: initial pilot study. Gastrointest Endosc 2005; 61: 746-752
14 Oh HC, Seo DW, Lee TY. et al. New treatment for cystic tumors of the pancreas: EUS-guided ethanol lavage with paclitaxel injection. Gastrointest Endosc 2008; 67: 636-642
15 Oh HC, Seo DW, Kim SC. et al. Septated cystic tumors of the pancreas: is it possible to treat them by endoscopic ultrasonography-guided intervention?. Scand J Gastroenterol 2009; 44: 242-247
16 Dimaio CJ, dewitt JM, Brugge WR. Ablation of pancreatic cystic lesions: the use of multiple endoscopic ultrasound-guided ethanol lavage sessions. Pancreas 2011; 40: 664-668
17 Park JK, Song BJ, Ryu JK. et al. Clinical outcomes of endoscopic ultrasonography-guided pancreatic cyst ablation. Pancreas 2016; 45: 889-894
18 Sainani NI, Saokar A, Deshpande V. et al. Comparative performance of MDCT and MRI with MR cholangiopancreatography in characterizing small pancreatic cysts. AJR Am J Roentgenol 2009; 193: 722-731
19 Sahani DV, Kambadakone A, Macari M. et al. Diagnosis and management of cystic pancreatic lesions. AJR Am J Roentgenol 2013; 200: 343-354
20 Waters JA, Schmidt CM, Pinchot JW. et al. CT vs MRCP: optimal classification of IPMN type and extent. J Gastrointest Surg 2008; 12: 101-109
21 Pilleul F, Rochette A, Partensky C. et al. Preoperative evaluation of intraductal papillary mucinous tumors performed by pancreatic magnetic resonance imaging and correlated with surgical and histopathologic findings. J Magn Reson Imaging 2005; 21: 237-244
22 de Jong K, van Hooft JE, Nio CY. et al. Accuracy of preoperative workup in a prospective series of surgically resected cystic pancreatic lesions. Scand J Gastroenterol 2012; 47: 1056-1063
23 Ardengh JC, Lopes CV, de Lima-Filho ER. et al. Impact of endoscopic ultrasound-guided fine-needle aspiration on incidental pancreatic cysts. A prospective study. Scand J Gastroenterol 2014; 49: 114-120
24 Brugge WR, Lewandrowski K, Lee-Lewandrowski E. et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004; 126: 1330-1336
25 Cizginer S, Turner BG, Bilge AR. et al. Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts. Pancreas 2011; 40: 1024-1028
26 Koito K, Namieno T, Nagakawa T. et al. Solitary cystic tumor of the pancreas: EUS-pathologic correlation. Gastrointest Endosc 1997; 45: 268-276
27 Morris-Stiff G, Lentz G, Chalikonda S. et al. Pancreatic cyst aspiration analysis for cystic neoplasms: mucin or carcinoembryonic antigen--which is better?. Surgery 2010; 148: 638-644 ; discussion 644-635
28 Al-Haddad M, dewitt J, Sherman S. et al. Performance characteristics of molecular (DNA) analysis for the diagnosis of mucinous pancreatic cysts. Gastrointest Endosc 2014; 79: 79-87
29 Gaddam S, Ge PS, Keach JW. et al. Suboptimal accuracy of carcinoembryonic antigen in differentiation of mucinous and nonmucinous pancreatic cysts: results of a large multicenter study. Gastrointest Endosc 2015; 82: 1060-1069
30 Kadayifci A, Al-Haddad M, Atar M. et al. The value of KRAS mutation testing with CEA for the diagnosis of pancreatic mucinous cysts. Endosc Int Open 2016; 4: E391-396
31 Khalid A, Zahid M, Finkelstein SD. et al. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointest Endosc 2009; 69: 1095-1102
32 Winner M, Sethi A, Poneros JM. et al. The role of molecular analysis in the diagnosis and surveillance of pancreatic cystic neoplasms. J Pancreas 2015; 16: 143-149
33 Konda VJ, Meining A, Jamil LH. et al. A pilot study of in vivo identification of pancreatic cystic neoplasms with needle-based confocal laser endomicroscopy under endosonographic guidance. Endoscopy 2013; 45: 1006-1013
34 Napoleon B, Lemaistre AI, Pujol B. et al. In vivo characterization of pancreatic cystic lesions by needle-based confocal laser endomicroscopy (ncle): proposition of a comprehensive ncle classification confirmed by an external retrospective evaluation. Surg Endosc 2016; 30: 2603-2612
35 Napoleon B, Lemaistre AI, Pujol B. et al. A novel approach to the diagnosis of pancreatic serous cystadenoma: needle-based confocal laser endomicroscopy. Endoscopy 2015; 47: 26-32
36 Nakai Y, Iwashita T, Park DH. et al. Diagnosis of pancreatic cysts: EUS-guided, through-the-needle confocal laser-induced endomicroscopy and cystoscopy trial: DETECT study. Gastrointest Endosc 2015; 81: 1204-1214
37 Krishna SG, Swanson B, Hart PA. et al. Validation of diagnostic characteristics of needle based confocal laser endomicroscopy in differentiation of pancreatic cystic lesions. Endosc Int Open 2016; 4: E1124-E1135
38 Kadayifci A, Atar M, Basar O. et al. Needle-Based confocal laser endomicroscopy for evaluation of cystic neoplasms of the pancreas. Dig Dis Sci 2017; 62: 1346-1353
39 Nakai Y, Isayama H, Chang KJ. et al. A pilot study of EUS-guided through-the-needle forceps biopsy (with video). Gastrointest Endosc 2016; 84: 158-162
40 Mittal C, Obuch JC, Hammad H. et al. Technical feasibility, diagnostic yield, and safety of microforceps biopsies during EUS evaluation of pancreatic cystic lesions (with video). Gastrointest Endosc 2018; 87: 1263-1269
41 Chai N, Feng J, Guo Y. et al. Preliminary study of single-operator cholangioscopy for diagnosing pancreatic cystic lesions. Gastrointest Endosc 2017; 86: 208-218
42 Zhu H, Jiang F, Zhu J. et al. Assessment of morbidity and mortality associated with endoscopic ultrasound-guided fine-needle aspiration for pancreatic cystic lesions: A systematic review and meta-analysis. Dig Endosc 2017; 29: 667-675
43 Guarner-Argente C, Shah P, Buchner A. et al. Use of antimicrobials for EUS-guided FNA of pancreatic cysts: a retrospective, comparative analysis. Gastrointest Endosc 2011; 74: 81-86
44 Klein A, Qi R, Nagubandi S. et al. Single-dose intra-procedural ceftriaxone during endoscopic ultrasound fine-needle aspiration of pancreatic cysts is safe and effective: results from a single tertiary center. Ann Gastroenterol 2017; 30: 237-241
45 Marinos E, Lee S, Jones B. et al. Outcomes of single-dose peri-procedural antibiotic prophylaxis for endoscopic ultrasound-guided fine-needle aspiration of pancreatic cystic lesions. United European Gastroenterol J 2014; 2: 391-396
46 Polkowski M, Jenssen C, Kaye P. et al. Technical aspects of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Technical Guideline – March 2017. Endoscopy 2017; 49: 989-1006
47 Varadarajulu S, Bang JY, Hebert-Magee S. Assessment of the technical performance of the flexible 19-gauge EUS-FNA needle. Gastrointest Endosc 2012; 76: 336-343
48 Cho MK, Choi JH, Seo DW. Endoscopic ultrasound-guided ablation therapy for pancreatic cysts. Endosc Ultrasound 2015; 4: 293-298
49 Gelczer RK, Charboneau JW, Hussain S. et al. Complications of percutaneous ethanol ablation. J Ultrasound Med 1998; 17: 531-533
50 Gomez V, Takahashi N, Levy MJ. et al. EUS-guided ethanol lavage does not reliably ablate pancreatic cystic neoplasms (with video). Gastrointest Endosc 2016; 83: 914-920
51 Linghu E, Du C, Chai N. et al. A prospective study on the safety and effectiveness of using lauromacrogol for ablation of pancreatic cystic neoplasms with the aid of EUS. Gastrointest Endosc 2017; 86: 872-880
52 Ebrahimi SRS, Enamzadeh E, Babaei H. An evidence-based review of off-label uses of polidocanol. Curr Clin Pharmacol 2017; 12: 223-230
53 Kim KH, mcgreevy K, La Fortune K. et al. Sonographic and cyst fluid cytologic changes after EUS-guided pancreatic cyst ablation. Gastrointest Endosc 2017; 85: 1233-1242
54 Dewitt J, dimaio CJ, Brugge WR. Long-term follow-up of pancreatic cysts that resolve radiologically after EUS-guided ethanol ablation. Gastrointest Endosc 2010; 72: 862-866
55 Oh HC, Seo DW, Kim SH. et al. Systemic effect of endoscopic ultrasonography-guided pancreatic cyst ablation with ethanol and paclitaxel. Dig Dis Sci 2014; 59: 1573-1577
56 Committee AT, dimaio CJ, Mishra G. et al. EUS core curriculum. Gastrointest Endosc 2012; 76: 476-481
57 Eisen GM, Dominitz JA, Faigel DO. et al. Guidelines for credentialing and granting privileges for endoscopic ultrasound. Gastrointest Endosc 2001; 54: 811-814
58 Teoh AYB, Dhir V, Kida M. et al. Consensus guidelines on the optimal management in interventional EUS procedures: results from the Asian EUS group RAND/UCLA expert panel. Gut 2018; 67: 1209-1228
59 Yachimski P, Varadarajulu S. Endoscopic ultrasound-guided pancreatic cyst ablation: more peril than promise?. Gastroenterology 2017; 153: 1183-1185
60 Fernandez-Del Castillo C. EUS treatment of pancreatic cysts: let's keep the alcohol (and the chemotherapy) locked in the cupboard. Gastroenterology 2011; 140: 2144-2145
61 Crippa S, Pezzilli R, Bissolati M. et al. Active surveillance beyond 5 years is required for presumed branch-duct intraductal papillary mucinous neoplasms undergoing non-operative management. Am J Gastroenterol 2017; 112: 1153-1161